Virus-like nanoparticle vaccine used to guard against RSV

Researchers at Georgia State University say they created a new RSV vaccine from virus-like nanoparticles. The respiratory virus infects the lungs and breathing passageways. And this new approach worked in protecting mouse models for the disease. "Recombinant engineered nanoparticle vaccines might be developed to prevent highly contagious respiratory pathogens such as RSV, as reported in this study," said Dr. Sang-Moo Kang, a professor in the Institute for Biomedical Sciences at Georgia State. Release

Sponsored By Paraza Pharma

Choosing the Right Pre-Clinical Collaborative Research Organization (CRO)

Learn about the key factors that are essential to creating a collaborative and productive working relationship to advance pre-clinical drug discovery programs.